Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
21 hedge funds and large institutions have $213K invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
5% more funds holding
Funds holding: 20 → 21 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
27% less capital invested
Capital invested by funds: $291K → $213K (-$78.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$551 |
| 2 |
TCSAM
Tyrus Capital S.A.M.
Monaco
|
+$379 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BHMP
Bardin Hill Management Partners
New York
|
-$15 |
CTV.WS Hedge Fund Activity: Q3 2023 in Review
21 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q3 2023, worth a combined $213K — down 27% from $291K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CTV.WS positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $551. The largest seller was Bardin Hill Management Partners, cutting an estimated $15.
- 21 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q3 2023, up from 20 in Q2 2023.
- Funds reported $213K of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q3 2023, down 27% quarter-over-quarter.
- 1 fund opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q3 2023 was Wolverine Asset Management, an estimated $551 added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q3 2023 was Bardin Hill Management Partners, an estimated $15 sold.
Based on aggregated 13F filings for Q3 2023.